| Trial name or title | Phase 2 study of the efficacy of daylight activated photodynamic therapy in the treatment of cutaneous leishmaniasis |
| Methods | Randomised, parallel assignment, open label |
| Participants | Age: ≥ 18 years |
| Interventions |
Group 1: photodynamic therapy Application of Metvix 16% cream followed by exposure to daylight for 2.5 h Group 2: cryotherapy for 2 times 20 s |
| Outcomes | Eradiation of amastigotes |
| Starting date | September 2009 |
| Contact information | Prof Claes D. Enk, Hadassah Medical Organization |
| Notes | — |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.